A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer.

Liu, Xin-Xiu; Lin, Guo-He; Wang, Bi-Cheng

Liu, Xin-Xiu; Lin, Guo-He; Wang, Bi-Cheng.

Affiliation

Liu XX; Cancer Center, Union Hospital, Tongji Medical College, Huaz.
Lin GH; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Wang BC; Cancer Center, Union Hospital, Tongji Medical College, Huaz.

Medicine (Baltimore) ; 101(45): e31751, 2022 Nov 11.

Article in En | MEDLINE | ID: mdl-36397323

Subject(s)

Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Humans; Carcinoma, Non-Small-Cell Lung/drug therapy; Carcinoma, Non-Small-Cell Lung/etiology; Lung Neoplasms/drug therapy; Lung Neoplasms/etiology; Docetaxel/therapeutic use; Bayes Theorem; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Immunotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google